I. Our Practice Tips Relating to Reasonable Protection for Biological Sequence Inventions Article 26 (4) of the Patent Law is intended to provide the inventor are a reasonable protection commensurate in scope with his contribution to the art.
Patent protection is at the core of the business for biotechnology companies, and for them, it is also crucial to understand that there exists strong differences amongst jurisdictions concerning what is considered as patentable subject matter, what disclosure is required,
Determining that the use of the post registered trademark,enterprise (shop) name infringes upon the prior enterprise (shop)name and constitutes unfair competition
a. The court should not accept the dispute over infringement between registered trademarks, which means that the standard use of post registered trademark constitutes no infringement upon the prior registered trademark.
The people's court should accept the lawsuit brought by the obligee on the grounds that the text or graph included in others' registered trademark infringes upon his prior rights such as the right of enterprise name.
